| 1 |
Strategies for Developing Design Spaces for Viral Clearance by Anion Exchange Chromatography During Monoclonal Antibody Production
Strauss DM, Cano T, Cai N, Delucchi H, Plancarte M, Coleman D, Blank GS, Chen Q, Yang B
Biotechnology Progress, 26(3), 750, 2010 |
| 2 |
Anion Exchange Chromatography Provides a Robust, Predictable process to Ensure Viral Safety of Biotechnology Products
Strauss DM, Gorrell J, Plancarte M, Blank GS, Chen Q, Yang B
Biotechnology and Bioengineering, 102(1), 168, 2009 |
| 3 |
Understanding the Mechanism of Virus Removal by Q Sepharose Fast Flow Chromatography During the Purification of CHO-Cell Derived Biotherapeutics
Strauss DM, Lute S, Tebaykina Z, Frey DD, Ho C, Blank GS, Brorson K, Chen Q, Yang B
Biotechnology and Bioengineering, 104(2), 371, 2009 |
| 4 |
Removal of Endogenous Retrovirus-Like Particles from CHO-Cell Derived Products Using Q Sepharose Fast Flow Chromatography
Strauss DM, Lute S, Brorson K, Blank GS, Chen Q, Yang B
Biotechnology Progress, 25(4), 1194, 2009 |
| 5 |
Generic/matrix evaluation of SV40 clearance by anion exchange chromatography in flow-through mode
Curtis S, Lee K, Blank GS, Brorson K, Xu Y
Biotechnology and Bioengineering, 84(2), 179, 2003 |
| 6 |
Buffer Exchange-Using Size-Exclusion Chromatography, Countercurrent Dialysis, and Tangential Flow Filtration - Models, Development, and Industrial Application
Kurnik RT, Yu AW, Blank GS, Burton AR, Smith D, Athalye AM, Vanreis R
Biotechnology and Bioengineering, 45(2), 149, 1995 |
